Background illustration for clinical trials search

Kidney Disease Clinical Trials

Browse 751 Kidney Disease clinical trials enrolling across the United States and Canada. 69 people applied to Kidney Disease studies last month. Search by city or state to find one near you.

Filter
1

Observational Approach Versus Surgical Intervention for Stones

for
Nephrolithiasis, Kidney Stone
Location: Hatboro PA, Irvine CA
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 6+

Code: NCT07718802

Recruiting

A Study Investigating the Safety of RO7795081 and How the Body Processes RO7795081 in People With Normal or Decreased Kidney Functions

for
Renal Impairment
Location: Miami Lakes FL, Orlando FL, St. Petersburg FL
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18 - 70+

Code: NCT07741604

Phase 1, Recruiting

Duke APOL1 Research Biorepository

for
End Stage Kidney Disease
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT04160507

Recruiting

A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

for
Focal Segmental Glomerulosclerosis
Location: Worcester MA, Valhalla NY, New Bern NC, Bethlehem PA,
Sponsor: Akebia Therapeutics

Sex: All

Age: 18+

Code: NCT07268638

Phase 2, Recruiting

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

for
Amyloidosis, Basal Cell Carcinoma, Biliary Tract Carcinoma,
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07285044

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of YOLT-203 in Children and Adults With Primary Hyperoxaluria Type 1 (PH1)

for
Primary Hyperoxaluria Type 1, PH1
Location: Birmingham AL, Aurora CO
Sponsor: YolTech Therapeutics Co., Ltd

Sex: All

Age: 6+

Code: NCT07587021

Phase 2, Recruiting

Managing Depressive Symptoms in ADPKD

for
Autosomal Dominant Polycystic Kidney Disease
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18 - 70

Code: NCT07745920

Recruiting

A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G

for
IgA Nephropathy, Lupus Nephritis (LN),
Location: Hollywood FL, Orangeburg SC, Lawrenceville GA
Sponsor: Akebia Therapeutics

Sex: All

Age: 16+

Code: NCT06419205

Phase 2, Recruiting

Modulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept Study

for
Clear Cell Renal Cell Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07187869

Phase 1, Recruiting

A Study in Adult Males With X-linked Congenital Nephrogenic Diabetes Insipidus to Test the Effects of NDI-5001 Given for Multiple Days and to Test How NDI-5001 is Tolerated and Taken up in the Body

for
Diabetes Insipidus
Location: Jacksonville FL, San Antonio TX
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

Sex: Male

Age: 18 - 55

Code: NCT07525960

Phase 1, Recruiting

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Orange City FL, Clermont FL, Detroit MI, Atlanta GA,
Sponsor: Inhibrx Biosciences, Inc

Sex: All

Age: 18+

Code: NCT04198766

Phase 1, Phase 2, Recruiting

REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma

for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Tampa FL, Zion IL, St Louis MO, Houston TX, Goodyear AZ,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07594106

Phase 1, Phase 2, Recruiting

A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)

for
Carcinoma, Renal Cell
Location: Boston MA, New York NY, Morristown NJ, Ottawa,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07489495

Phase 3, Recruiting

FST Analysis Supporting Timely Therapy and Risk Assessment Via Clinical Decision Support for Kids

for
Acute Kidney Injury, Renal Replacement Therapy,
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 0+

Code: NCT07718464

Recruiting

Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

for
Lupus Nephritis
Location: Orchard Park NY
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06711887

Phase 3, Recruiting

Renal Impairment Study for Oral EC5026

for
Chronic Kidney Disease
Location: Sacramento CA
Sponsor: EicOsis Human Health Inc.

Sex: All

Age: 55+

Code: NCT07694544

Phase 1, Recruiting

A Study of Luspatercept in People With Anemia

for
Anemia, Chronic Kidney Disease
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07725497

Phase 2, Recruiting

Wellness & Workforce Solution for Lupus/Lupus Nephritis

for
Lupus Nephritis
Location: Atlanta GA
Sponsor: Morehouse School of Medicine

Sex: Female

Age: 18+

Code: NCT06217107

Recruiting

Biomarker and Renal Angina Validation to Assess Heart-Kidney Outcomes After Amino Acid Therapy

for
Acute Kidney Injury, Mechanical Ventilation
Location: Cincinnati OH
Sponsor: Dana Fuhrman

Sex: All

Age: 0 - 18

Code: NCT07212595

Phase 2, Recruiting

BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants

for
Chronic Kidney Disease, Stage 4,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 18 - 65

Code: NCT06741072

Phase 1, Recruiting

What are clinical trials for kidney disease?

Clinical trials for kidney disease are research studies designed to test new treatments, interventions, or diagnostic methods aimed at improving the management and outcomes of kidney conditions including kidney disease. These trials may involve experimental medications, innovative therapies, surgical techniques, or lifestyle interventions.

The importance of kidney disease clinical trials

Kidney disease clinical trials are crucial because they help advance our understanding of kidney disorders so that more effective treatments can be developed. These trials test new drugs, therapies, and diagnostic methods, aiming to improve patient outcomes, slow disease progression, and enhance quality of life.

Clinical trials for kidney disease also provide valuable data on the safety and efficacy of new interventions, which can lead to better management strategies and potential cures. Without clinical trials, the development of innovative solutions and improvements in care for kidney disease would be limited, potentially leaving patients with fewer options and suboptimal outcomes.

Types of kidney disease clinical trials

Participation in a clinical trial for kidney disease

Who can take part in a kidney disease clinical trial?

How to enroll in a clinical trial for kidney disease